Epizyme

EPZM

EPZM
Epizyme Stock Quote
$10.27 $0.26 2.6%
BATS BZX Real Time Price as of October 15, 2019, 4:00 p.m. EDT View Interactive EPZM Charts

Epizyme Inc is a clinical stage biopharmaceutical company that discovers develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers.

News & Analysis: Epizyme

All

Market Moves











Interactive Chart